CH
Global X China Biotech Innovation ETF (CHB)
·Financial Services·Asset Management
$6.64
—
Mkt Cap $1.39M
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$210.45
Range $142.74 – $247.05
Implied Upside
+3069.4%
Consensus $210.45 vs current $6.64